Skip to content

ESLA

Estrella Immunopharma, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.53
+0.57%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
P/S forward
0.23x

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
-3.10x
Price / sales
Price / cash flow
-2.45x

Enterprise value

Enterprise value
$22.9M
EV / sales
EV / EBITDA
-2.34x
EV / EBIT
-2.34x
Market cap
$23.0M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026